GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 218 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $187,000 | -6.0% | 4,600 | 0.0% | 0.00% | – |
| Q4 2020 | $199,000 | -21.7% | 4,600 | 0.0% | 0.00% | – |
| Q3 2020 | $254,000 | -12.4% | 4,600 | 0.0% | 0.00% | – |
| Q2 2020 | $290,000 | +23.4% | 4,600 | 0.0% | 0.00% | – |
| Q1 2020 | $235,000 | -35.8% | 4,600 | 0.0% | 0.00% | – |
| Q4 2019 | $366,000 | +64.1% | 4,600 | 0.0% | 0.00% | – |
| Q3 2019 | $223,000 | +18.0% | 4,600 | +27.8% | 0.00% | – |
| Q2 2019 | $189,000 | -1.0% | 3,600 | 0.0% | 0.00% | – |
| Q1 2019 | $191,000 | +29.1% | 3,600 | 0.0% | 0.00% | – |
| Q4 2018 | $148,000 | -70.5% | 3,600 | -67.6% | 0.00% | -100.0% |
| Q2 2018 | $502,000 | -8.1% | 11,100 | -1.8% | 0.00% | 0.0% |
| Q1 2018 | $546,000 | -78.2% | 11,300 | -82.2% | 0.00% | -75.0% |
| Q4 2017 | $2,499,000 | – | 63,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 177,414 | $14,103,000 | 11.50% |
| Fernwood Investment Management, LLC | 258,012 | $20,509,000 | 9.81% |
| Perceptive Advisors | 5,865,726 | $466,266,000 | 9.26% |
| ArchPoint Investors | 186,756 | $14,845,000 | 4.54% |
| STANSBERRY ASSET MANAGEMENT, LLC | 115,638 | $9,192,000 | 3.74% |
| Camber Capital Management LP | 730,000 | $58,028,000 | 2.95% |
| Profit Investment Management, LLC | 46,873 | $3,726,000 | 2.50% |
| Casdin Capital, LLC | 300,000 | $23,847,000 | 2.19% |
| SECTORAL ASSET MANAGEMENT INC | 174,594 | $13,878,000 | 2.07% |
| Corriente Advisors, LLC | 40,000 | $3,180,000 | 1.71% |